GlaxoSmithKline in France...

Global pharma giant plans to invest 500 million euros in its vaccine production plant in northern France to expand capacity.

Europe's largest drug maker says investment will help meet increasing demand for its adult and pediatric vaccines, including the new cancer shot Cervarix, which is expected to gain regulatory approval in 2007. GlaxoSmithKline has been investing heavily in vaccines business and has been buying companies and technologies.

Source: Earth Times.org

Need help with your packaging project?
We’ve done the legwork to identify and vet experienced packaging and processing consultants you can contact directly for your next project. Decades of combined experience in packaging line engineering, machinery selection, package and materials development, and food processing operations.
See your advisor options now.
Need help with your packaging project?